Abbott Laboratories

Organisation

100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400

Headquarters

115000

Employees

Health Technology

Industry

Robert Ford

Abbott Laboratories, headquartered in Chicago, Illinois, was founded in 1888 by a physician named Dr Wallace Calvin. His purpose was to improve people's well-being and help them reach their full potential at different stages of their lives. Founded as a drug formulation company, today, Abbott Laboratories is a worldwide leader in healthcare, medical devices, nutritional products, and pharmaceutical drugs. Even though it reached the shores of India a century ago, it is still regarded as one of the largest healthcare product companies. With a focus on cardiovascular, diagnostic, diabetes, and neuromodulation products, some of its popular brands include Pedialyte, Glucerna, Similac, Ensure, and iStat. 

Abbott opened its first international office in London in 1907, and currently operates in over 160 countries. Its growth is also a result of strategic acquisitions. Abbott’s recent acquisitions include Kalo Pharma International in 2014, which doubled its brand generic drug portfolio. It acquired Tendyne in 2015 and along with it the company’s minimally invasive mitral valve replacement therapies. Another gem in the crown is the acquisition of Alere in 2016, which gave Abbott access to the largest mail-order diabetic supplier, Arriva Medical. 

Along with strategic acquisitions, the company is dedicated to gaining a strong competitive advantage. With the onset of COVID-19, the company has developed various antibody tests that have been granted emergency-use authorization. According to Forbes, Abbott Laboratories' fast and low-cost testing methods have expedited the detection of COVID-19 virus. For its 2030 sustainability plan, the company is gearing up to introduce revolutionary products such as BinaxNOW, a COVID-19 test, and FreeStyle Libre, an innovative glucose monitoring device. 
Abbott’s future plans are centred around providing cutting-edge technologies at affordable prices to even the most vulnerable sections of society.
 
Currently Abbott Laboratories has a market cap of $196.19 Billion. It has a P.E ratio of 35.31. The shares of Abbott Laboratories are trading at $110.25.
 .

Price

Target

Abbott Laboratories (ABT) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Abbott Laboratories (ABT) share price will touch around $133.33 in next 12-months.

Currently 29 wall-street analysts regularly analyze the financials of Abbott Laboratories on a frequent basis to provide recommendations along with target share price. 29 analysts offering 12-month price forecasts for Abbott Laboratories (ABT) have a share price target of $133.33. This median of share price forecast represents a 20.99% upside from the latest price of $110.2 as on 13.03.26.

Abbott Laboratories (ABT) Share Price Forecast

Home

US Stocks

Abbott Laboratories (ABT)

Abbott Laboratories Stock Forecast

Abbott Laboratories Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Abbott Laboratories (ABT): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Abbott Laboratories's share price and its median forecast price. As on 13.03.26, the difference is -11.37%

Abbott Laboratories Forecast and Target Price

Abbott Laboratories (ABT) Share Price Forecast

Abbott Laboratories (ABT) Price vs Consensus Price Target

Abbott Laboratories (ABT) Share Price Forecast v/s Share Price Today

Abbott Laboratories (ABT): Difference between Current Price & Median Forecasted Price

Abbott Laboratories (ABT) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price